Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1956 1
1957 4
1958 2
1959 2
1960 2
1961 1
1962 2
1963 5
1964 7
1965 2
1966 3
1967 1
1968 2
1969 8
1970 4
1971 4
1972 10
1973 5
1974 3
1975 12
1976 8
1977 10
1978 8
1979 6
1980 6
1981 8
1982 13
1983 14
1984 10
1985 9
1986 15
1987 26
1988 11
1989 19
1990 18
1991 29
1992 36
1993 32
1994 31
1995 38
1996 34
1997 29
1998 50
1999 39
2000 30
2001 46
2002 44
2003 50
2004 47
2005 57
2006 48
2007 55
2008 64
2009 52
2010 58
2011 61
2012 56
2013 55
2014 62
2015 58
2016 39
2017 55
2018 55
2019 49
2020 70
2021 82
2022 76
2023 71
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

1,818 results

Results by year

Filters applied: . Clear all
Page 1
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.
Illes P, Müller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F. Illes P, et al. Among authors: jacobson ka. Br J Pharmacol. 2021 Feb;178(3):489-514. doi: 10.1111/bph.15299. Epub 2020 Dec 21. Br J Pharmacol. 2021. PMID: 33125712 Free PMC article. Review.
Tuberculosis.
Jacobson KR. Jacobson KR. Ann Intern Med. 2017 Feb 7;166(3):ITC17-ITC32. doi: 10.7326/AITC201702070. Ann Intern Med. 2017. PMID: 28166561 Review.
Editorial: Purinergic Pharmacology.
Ciruela F, Jacobson KA. Ciruela F, et al. Among authors: jacobson ka. Front Pharmacol. 2019 Jan 23;10:21. doi: 10.3389/fphar.2019.00021. eCollection 2019. Front Pharmacol. 2019. PMID: 30728779 Free PMC article. No abstract available.
Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation.
Turpin W, Dong M, Sasson G, Raygoza Garay JA, Espin-Garcia O, Lee SH, Neustaeter A, Smith MI, Leibovitzh H, Guttman DS, Goethel A, Griffiths AM, Huynh HQ, Dieleman LA, Panaccione R, Steinhart AH, Silverberg MS, Aumais G, Jacobson K, Mack D, Murthy SK, Marshall JK, Bernstein CN, Abreu MT, Moayyedi P, Paterson AD; Crohn’s and Colitis Canada (CCC) Genetic, Environmental, Microbial (GEM) Project Research Consortium; Xu W, Croitoru K. Turpin W, et al. Among authors: jacobson k. Gastroenterology. 2022 Sep;163(3):685-698. doi: 10.1053/j.gastro.2022.05.037. Epub 2022 May 26. Gastroenterology. 2022. PMID: 35643175
Gut Microbiome Composition Is Associated With Future Onset of Crohn's Disease in Healthy First-Degree Relatives.
Raygoza Garay JA, Turpin W, Lee SH, Smith MI, Goethel A, Griffiths AM, Moayyedi P, Espin-Garcia O, Abreu M, Aumais GL, Bernstein CN, Biron IA, Cino M, Deslandres C, Dotan I, El-Matary W, Feagan B, Guttman DS, Huynh H, Dieleman LA, Hyams JS, Jacobson K, Mack D, Marshall JK, Otley A, Panaccione R, Ropeleski M, Silverberg MS, Steinhart AH, Turner D, Yerushalmi B, Paterson AD, Xu W; CCC GEM Project Research Consortium; Croitoru K. Raygoza Garay JA, et al. Among authors: jacobson k. Gastroenterology. 2023 Sep;165(3):670-681. doi: 10.1053/j.gastro.2023.05.032. Epub 2023 May 30. Gastroenterology. 2023. PMID: 37263307
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn's disease highlight earliest events of pathogenesis.
Leibovitzh H, Lee SH, Raygoza Garay JA, Espin-Garcia O, Xue M, Neustaeter A, Goethel A, Huynh HQ, Griffiths AM, Turner D, Madsen KL, Moayyedi P, Steinhart AH, Silverberg MS, Deslandres C, Bitton A, Mack DR, Jacobson K, Cino M, Aumais G, Bernstein CN, Panaccione R, Weiss B, Halfvarson J, Xu W, Turpin W, Croitoru K; Crohn’s and Colitis Canada (CCC) Genetic, Environmental, Microbial (GEM) Project Research Consortium. Leibovitzh H, et al. Among authors: jacobson k. Gut. 2023 Aug;72(8):1462-1471. doi: 10.1136/gutjnl-2022-328421. Epub 2023 Feb 14. Gut. 2023. PMID: 36788016
New paradigms in purinergic receptor ligand discovery.
Jacobson KA, Pradhan B, Wen Z, Pramanik A. Jacobson KA, et al. Neuropharmacology. 2023 Jun 1;230:109503. doi: 10.1016/j.neuropharm.2023.109503. Epub 2023 Mar 13. Neuropharmacology. 2023. PMID: 36921890 Review.
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
Leibovitzh H, Lee SH, Xue M, Raygoza Garay JA, Hernandez-Rocha C, Madsen KL, Meddings JB, Guttman DS, Espin-Garcia O, Smith MI, Goethel A, Griffiths AM, Moayyedi P, Steinhart AH, Panaccione R, Huynh HQ, Jacobson K, Aumais G, Mack DR, Abreu MT, Bernstein CN, Marshall JK, Turner D, Xu W; CCC GEM Project Research Consortium; Turpin W, Croitoru K. Leibovitzh H, et al. Among authors: jacobson k. Gastroenterology. 2022 Nov;163(5):1364-1376.e10. doi: 10.1053/j.gastro.2022.07.004. Epub 2022 Jul 16. Gastroenterology. 2022. PMID: 35850197
Editorial: Purinergic pharmacology, Volume II.
Ciruela F, Jacobson KA. Ciruela F, et al. Among authors: jacobson ka. Front Pharmacol. 2023 May 16;14:1200187. doi: 10.3389/fphar.2023.1200187. eCollection 2023. Front Pharmacol. 2023. PMID: 37261289 Free PMC article. No abstract available.
1,818 results